Thousand Oaks, CA, United States of America

Dory King

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Dory King: Innovator in Pharmaceutical Formulations

Introduction

Dory King is a prominent inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms for medications. With a total of 3 patents to her name, Dory has established herself as a key player in the industry.

Latest Patents

Dory King's latest patents focus on formulations of apremilast. These patents describe oral dosage forms that include a core tablet with a drug layer comprising apremilast and hypromellose acetate succinate (HPMCAS) in an amorphous solid dispersion. Additionally, the core tablet features a swellable layer made of one or more swellable polymers, along with a coating layer that contains at least one drug release orifice. The innovative oral dosage forms provide once-a-day dosing of apremilast, making them suitable for treating diseases or disorders that can be improved by inhibiting phosphodiesterase subtype IV (PDE4).

Career Highlights

Dory is currently employed at Amgen Inc., a leading biotechnology company. Her work has been instrumental in advancing the formulation of medications that enhance patient compliance and therapeutic outcomes.

Collaborations

Dory collaborates with talented individuals such as Nathan Bennette and William Brett Caldwell, contributing to a dynamic team focused on pharmaceutical innovation.

Conclusion

Dory King's contributions to the field of pharmaceutical formulations highlight her expertise and dedication to improving patient care through innovative drug delivery systems. Her work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…